Two medicines for polycystic ovaries

Patients with polycystic ovary syndrome usually need to take drugs such as ethinyl estradiol cyproterone tablets and letrozole tablets as directed by their doctors. Polycystic ovary syndrome may be related to factors such as insulin resistance and high androgen levels, and usually manifests as irregular menstruation, acne and other symptoms.

1. Ethinyl Estradiol Cyproterone Tablets

Ethinyl estradiol and cyproterone tablets are compound preparations containing ethinyl estradiol and cyproterone, which can regulate hormone levels in the body and improve symptoms such as oligomenorrhea and hirsutism caused by polycystic ovary syndrome. This medicine needs to be taken periodically, and the common dosage form is tablets. Adverse reactions such as breast tenderness and nausea may occur during medication, and liver function needs to be monitored regularly. Contraindications include those with abnormal liver function, those with a history of thrombosis, and pregnant women.

2. Letrozole tablets

Letrozole tablets are aromatase inhibitors that inhibit the conversion of androgens into estrogen, thereby reducing local estrogen levels in the ovaries and promoting follicle development. It is suitable for patients with polycystic ovary syndrome and ovulation disorders. The common dosage form is film-coated tablets. Side effects such as hot flashes and joint pain may occur after taking the medication, and it is necessary to monitor follicle development with ultrasound under the guidance of a doctor. It is contraindicated in patients with severe hepatic insufficiency, and pregnancy must be avoided during medication.

Patients with polycystic ovary syndrome need to maintain a low glycemic index diet, eat broccoli, oatmeal and other dietary fiber-rich foods in moderation, and avoid high-sugar and high-fat diets. 150 minutes of moderate-intensity exercise, such as brisk walking and swimming, per week can help improve insulin sensitivity. It is recommended to record changes in the menstrual cycle, regularly review hormone levels and ultrasound, and avoid adjusting drug dosage or interrupting treatment on your own.